Existing drug class may help patients with skin cancer that resists standard treatments

by

Increased activity in a specific biological pathway may explain why many patients with a deadly form of skin cancer do not respond to the latest cancer treatments, a new study shows.

Leave A Comment

Your email address will not be published. Required fields are marked *